Table 4.

Linear regression analysis for chloroalkane and chloroalkene degradation predicting FLC λ.

Variable	B	SE	β	t	p	VIF
Constant	6.998	0.995		7.328	< 0.005
Chloroalkane and chloroalkene degradation	-9.391	4.564	-0.197	-2.058	0.042	1.002
Hyperlipidemia	-0.922	0.325	-0.271	-2.841	0.005	1.008
Non-Hyperlipidemia	0
R 2	0.117
F	6.453
P	0.002

Multiple linear analysis was used to assess the association between chloroalkane and chloroalkene degradation and the serum FLC λ concentration, with adjustment for the confounder hyperlipidemia. In the analysis, hyperlipidemia was treated as a dichotomous variable.